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Summary.-Immunoreactive collagenase has been demonstrated in 5/14 specimens
of cutaneous secondary melanomas. In contrast, very little enzyme was seen in 10
specimens of normal human skin. All specimens were fixed within minutes of
excision. These findings support the hypothesis that collagenase facilitates connec-
tive-tissue breakdown which is associated with tumour invasiveness and metastatic
spread.
THE PRECISE FACTORS which eniable
tumour cells to detach from each other,
and to penetrate local physical barriers
presented by the extracellular matrix, re-
main obscure. Several groups have pro-
posed that some tumours and malignant
cells secrete matrix-degrading or colla-
genolytic enzymes to facilitate their in-
vasion of surrounding tissues (for review
see Woolley et al., 1980). This has been
supported by reports of collagenolytic
activity obtained either from tissue culture
or the extraction of various tumours, and
such studies have suggested the involve-
ment of neutral collagenase in tumour in-
vasion (e.g. Dresden et al., 1972; McCros-
kery et al., 1975; Bauer et al., 1977; Liotta
et al., 1979). However, the cellular origin
of collagenase has been in doubt because
of the heterogeneity of most tumour
specimens. One approach tothis problem is
the use of immunolocalization techniques
using an antibody specific to human
collagenase. We have therefore examined
specimens of cutaneous melanomas and
normal skin for immunoreactive collagen-
ase, and have demonstrated that the
enzyme is more frequently found in
malignant tissues, especially in locations
wvhich histologically show signs of collagen
loss.
MATERIALS AND METHODS
Collagenase antibody.-A specific antibody
to human collagenase has been raised in sheep
and characterized by double diffusion, en-
zyme inhibition and immunoelectrophoretic
techniques (Woolley et al., 1977, 1979, 1980).
Collagenases obtained from various specimens
of cultured gastric adenocarcinomas or skin
melanomas showed cross-reactivity with the
antibody, as demonstrated by double diffu-
sion (Woolley et al., 1980). Previous studies
have showAn that the antibody has poor re-
activity with latent enzyme or collagenase
inhibited by its natural inhibitors, and we
believe that most of our immunofluorescence
observations reflect active, often collagen-
bound enzyme (Woolley et al., 1979, 1980).
Immunolocalization.-The specific sheep
IgG antibody was separated from other
immunoglobulins by affinity chromatography
on a collagenase-Sepharose 4B column and
eluted with 0-05M sodium citrate buffer
(pH 3.2). The purified immune IgG was
dialysed against phosphate-buffered saline
(PBS) containing 0.02% sodium azide as
preservative and used at a concentration of
50-100 ,ug IgG/ml.
Operative specimens of cutaneous melan-
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oina were frozen in liquid N2 within a few
minutes of excision and stored at -70°C.
Frozen sections (6-7 yim) were fixed for 1 min
in freshly prepared 4% formalin, washed in
PBS and examined by the inidirect method of
immunofluorescence, using the collagenase
antibody in conjunction with FITC-labelled
rabbit (anti-sheep IgG) immunoglobulins as
described previously (Woolley et al., 1977).
Control tissue sections exposed to (a) non-
immune sheep IgG in place of antibody, (b)
immune sheep IgG previously adsorbed with
pure collagenase, and (c) the FITC-conju-
gated antibody alone, accompanied each
fluorescence study and were consistently
negative.
Tissue sections were examined by incident
fluorescence microscopy, using a Vickers M41
Photoplan microscope fitted with two FITC
No. 5 interference exciter filters and a 200W
mercury-vapour lamp. Fluorescence micro-
graphs were made with Kodak Ektachrome
ASA 200 film. Frozen sections from all tissue
specimens were also stained with haema-
toxylin and eosin or van Gieson's/celestine
blue for light microscopy.
Melanoma specimens.-All melanoma speci-
mens were obtained from patients with skin
primaries treated by wide excision with or
without grafting, and block dissection. The
disease biopsy specimens were obtained after
a variable interval from primary treatment,
and always in the presence of disseminated
disease. One specimen was a local recurrence,
the remainder were metastases: 2 from
regional nodes and 11 from skin nodules.
The specimens of control skin were ob-
tained from patients undergoing routine
surgical procedures. The site of the skin
sample varied according to the procedure
which included mammaplasty, amputation
and plastic surgery.
RESULTS
Fourteen specimens ofhuman cutaneous
melanoma were subjected to collagenase
immunolocalization, and positive findings
were observed in 5. In contrast, very little
immunoreactive enzyme was found in 10
specimens of normal skin. All specimens
were fixed within minutes of surgery.
Fig. I shows2examplesofskin containing
infiltrations oftumourcells where immuno-
reactive collagenase is associated with the
dermal tissue. The regions shown were in
close association with invading secondary
melanoma. Most ofthe fluorescence is asso-
ciated with the dermal collagen and
stromal elements bounding the islands of
tumour cells. There is no significant stain-
ing of tumour cells or the epithelium. In
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Fim. 1. Immunolocalization ofcollagenase in
s.e. secondary melanomas and normal skin.
a and b: FITC fluorescence associated with
dermal collagen and the stromal structures
bounding the pockets of melanoma (Ale). Deeper regions of the dermis (Der) and
theepithelium (Ep) arenegativefor enzyme,
as are most of the tumour-cell islands.
c: Frozen section of normal skin showing
no evidence ofimmunoreactive collagenase.
Bar= 50 ,-m.
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contrast, normal skin (shown in Fig. Ic)
was usually devoid of immunoreactive
collagenase, although single or small
groups of dermal fibroblasts or basal cells
occasionallv demonstrated enzyme.
Fig. 2 shows 2 different observations
FiG. 2.-Immunolocalization of collagenase
associated with invasive pockets of mela-
noma cells. a: Frozen section through
melanomafixed atexcision. The section con-
tains islands of tumour cells bounded by
collagenous stromal tissue and dermal
collagen. H & E. b: FITC fluorescence
associated with individual cells close to
the tumour-cell islands as shown in (a).
The tumour-cell islands and surrounding
stroma appear negative for enzyme. c:
FITC fluorescence associated with stromal
tissue bounding the tumour-cell islands
and other dermal structures. Tumour cells
appear negative and source of enzyme is
uncertain. Bar= 25 ,um.
FiG. 3.-Immunolocalization of collagenase
in s.c. secondary melanoma. a Frozen
section showing the spread of tumour cells
into dermal tissue with concomitant break-
down of collagenous structures. H & E.
b: FITCfluorescenceassociated withresidual
dermal collagen in similar location to that
shown in a. Most ofthe fluorescence reflects
collagen-bound enzyme, with relatively few
cells producing enzyme. c: Control tissue
section treated with the antibody IgG prep-
aration previously adsorbed with pure
collagenase. The negative response of the
same tissue location as shown in b confirms
specificity of the antibody. Bar= 25 ,um.
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malignant cells have spread into dermal
tissue. This process clearly involves a loss
ofcollagen, and immunoreactive collagen-
ase is often associated with such locations.
Similarly, inFig. 4a aheterogeneous popu-
lation of cells, some containing melanin
pigments, is invading dermal connective
tissue. Collagenase was shown to be asso-
ciated with both structural elements and
a few cells.
The data presented here confirm an in
vivo role for collagenase in melanomas and
surrounding connective tissues. Its asso-
ciation with collagen in locations where
tumour cells are spreading into the matrix
suggests the enzyme facilitates this in-
vasive process. As yet we cannot identify
conclusively the cells responsible for
collagenase production in such locations.
Our present observations suggest that
tumour cells are frequently associated
with enzyme production in vivo, but this
is usually a microenvironmental rather
than a generalized event.
DISCUSSION
Although neutral collagenase has been
reported from a variety of tumour tissues,
it is uncertain which cells are responsible
for its production. Tane et al. (1978) have
reported that pure populations of human
malignant melanoma cells produce an
extractable collagenase in vitro, and simi-
lar studies have shown that different
populations of tumour cells have different
collagenolytic abilities against basement-
membrane collagen (Liotta et al., 1977,
1980). However, most tissues and several
cell types produce collagenase when sub-
jected to in vitro culture techniques, but
this does not necessarily imply that they
do this in vivo, only that they have the
potential to do so. Immunolocalization
techniques on tissues fixed immediately
after excision provide more direct infor-
mation on both the distribution and cellu-
lar origin ofcollagenase in various tumour
specimens.
The immunolocalization studies re-
ported here have shown great variability
in the amount ofimmunoreactive enzyme.
FIG. 4.-Immunolocalization of..collagenase
at the junction of melanoma and dermis.
a: Frozen section fixed at excision, showing
junctional region with a mixed population
of cells and dermal, collagen. b: FITC
fluorescence mainly associated with the cel-
lular region of an adjacent section to that
shown in a. The melanin-pigmente(I cells
(centre) appear negative for enzyme, but
other cells are positive. Bar= 25 /-Lm.
relating to pockets ofmalignant cells with
surrounding dermal tissue. The individual
cells which demonstrate FITC-fluoreseence
in close proximity to the tumour islands
have not been identified, but may repre-
sent either dermal fibroblasts, macro-
phages ormigrating tumour cells (Fig. 2b).
InFig. 2c immunoreactive enzyme is asso-
ciated with the stromal elementsbounding
the islands oftumour cells. Although these
tumour cells appear negative for collagen-
ase the surrounding matrix appears to be
underaoing extensive remodellina. Even
within the same tissue section similar
regions were often negative for enzyme,
suggesting that collagenase production is
often microenvironmental and transient.
Fig. 3 shows the outer border of a
melanoma where dense infiltrations ofD. E. WOOLLEY AND C. A. GURAFTON
In the majority of specimens relatively
little enzyme has been detectable, whereas
in others enzyme has been associated with
regions of connective tissue undergoing
various degrees of degradation, as judged
histologically. In those specimens of
melanoma or normal skin which revealed
immunoreactive enzyme, it usually ap-
peared restricted to stromal elements sur-
rounding either single cells or small
groups, suggesting microenvironmental
rather than widespread activity.
The cells responsible for the production
of collagenase in these melanomas have
been difficult to identify. As yet it is un-
clear whether or not tumour cells act as
collagenase producers or stimulators of
host cells, but this may well vary with the
type and/or location of each tuimour. In
most specimens, the failure to detect sig-
nificant intracellular enzyme suggests that
collagenase is not stored or packaged
within the cell, but is probably synthesized
and released as and when required. Malig-
niant tissues are often characterized by the
infiltration of various cell types, such as
macrophages, lymphocytes, mast cells and
tumour cells. These are all likely t-o have a
profound effect on the local environmental
physiology, collagenase production prob-
ably being modulated by complex cell:cell
interactions and a variety of local and
systemic humoral factors (Dayer et al.,
1980; Biswas et al., 1978; Woolley &
Evanson, 1980).
It has often been proposed that the
secretion of collagenase may be important
in facilitating tumour cell spread or in-
vasion into suirrounding host tissues. How-
ever, it seems unlikely that this property is
sufficient in itself to explain tumour-cell
invasiveness, and other aggressive factors
such as motility and high metabolic
activity are probably essential for penetra-
tion of the connective-tissue matrix. The
recent finding that certain murine tumour
cells secrete an enzyme which effectively
degrades basement-membrane collagen, in
contrast to other tissue collagenases, is of
great interest in relation to matrix degra-
dation and metastatic potential (Liotta
et al., 1979, 1980). As yet we do not know
whether our antibody cross-reacts with
such an enzyme.
We have not been able to derive any
clinical correlations with immunolocaliza-
tion of collagenase, despite the relatively
homogeneous clinical group with skin
primaries from whom metastatic cuta-
neous deposits were sampled at the time
of widespread disease. The prognostic
variables of primary site, histological
classification, sex of patient and subse-
quent treatment require greater numbers
for meaningful analysis. Multiple samples
from involved organs of a single case
would make an interesting study, but our
interpretation of any such data must
await a better understanding of the
collagenolytic mechanisms involved in
trumour invasiveness.
From our present findings we conclude
that collagenase has an in vivo role in con-
nective-tissue degradation which is asso-
ciated with the invasive behaviour of
human secondary melanomas. The micro-
environmental nature of our immuno-
localization observations suggest a spor-
adic or transient production of collagenase
at specific sites. This probably explains
the absence of immunoreactive enzyme
from many specimens, and suggests that
sampling time in relation to the "meta-
static physiology" of any specimen is of
crucial importance for the studies re-
ported here. The fact that all tumour
specimens, including those showing no
immunoreactive collagenase at the time of
excision, demonstrated collagenase pro-
duction when subjected to tissue-culture
techniques for 3-4 days (unpublished
observations) confirms that all the melan-
oma specimens examined had the potential
to elaborate collagenase. Further work is
now required to obtain an understanding
of how this enzyme is produced and regu-
lated in vivo. Such an understanding may
eventually encourage therapeutic ap-
proaches to the control of collagenase
activity, possibly improving the manage-
ment of tumours bya preventing tumour
spread.
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